Back
 

View:
Mini 
BasicThis view is available after user registration.
 
ShortThis view is available when you buy a license.
 
StandardThis view is available when you buy a license.
 
CompleteThis view is available when you buy a license.
 

Cetuximab 250 / Radiation, Squamous Cell Carcinoma of the Skin, Cycle 2+

Protocol-ID: 2164 V1.0 (Mini), CETU250/Radiation, CSCC, C2+

Indication(s)

  • Squamous Cell Carcinoma of the Skin; ICD-10 C44.9
ST
Radiotherapy: simultaneous Radiation
From cycle 2: Irradiation up to a total dose of 55-66 Gy in 22-30 fractions.
The publishers and authors assume no liability for the accuracy of the contents. The application is at the own responsibility of the treating physician. ©Onkopti.

Valid since: 14.10.2022